These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 22762136

  • 1. Hepatitis C therapy in non-genotype 1 patients: the near future.
    Wartelle-Bladou C, Le Folgoc G, Bourlière M, Lecomte L.
    J Viral Hepat; 2012 Aug; 19(8):525-36. PubMed ID: 22762136
    [Abstract] [Full Text] [Related]

  • 2. The race for interferon-free HCV therapies: a snapshot by the spring of 2012.
    De Clercq E.
    Rev Med Virol; 2012 Nov; 22(6):392-411. PubMed ID: 22936636
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of hepatitis C: current status and perspectives].
    Pol S, Corouge M.
    Rev Prat; 2014 May; 64(5):605-12. PubMed ID: 24923038
    [Abstract] [Full Text] [Related]

  • 4. [Direct antiviral treatment strategies in chronic hepatitis C].
    Neumann-Haefelin C, Blum HE, Thimme R.
    Dtsch Med Wochenschr; 2012 Jun; 137(25-26):1360-5. PubMed ID: 22653493
    [Abstract] [Full Text] [Related]

  • 5. Chronic hepatitis C: treatments of the future.
    Bourlière M, Khaloun A, Wartelle-Bladou C, Oules V, Portal I, Benali S, Adhoute X, Castellani P.
    Clin Res Hepatol Gastroenterol; 2011 Dec; 35 Suppl 2():S84-95. PubMed ID: 22248700
    [Abstract] [Full Text] [Related]

  • 6. [Hepatitis C virus: 25 years-old, the end?].
    Pol S.
    Med Sci (Paris); 2013 Nov; 29(11):998-1003. PubMed ID: 24280503
    [Abstract] [Full Text] [Related]

  • 7. Rapid progression of antiviral treatments of chronic hepatitis C virus infection.
    Pol S, Corouge M, Mallet V, Sogni P.
    Minerva Gastroenterol Dietol; 2013 Jun; 59(2):161-72. PubMed ID: 23831907
    [Abstract] [Full Text] [Related]

  • 8. Review of direct-acting antiviral agents for the treatment of chronic hepatitis C.
    Shah N, Pierce T, Kowdley KV.
    Expert Opin Investig Drugs; 2013 Sep; 22(9):1107-21. PubMed ID: 23735127
    [Abstract] [Full Text] [Related]

  • 9. Antiviral strategies in hepatitis C virus infection.
    Sarrazin C, Hézode C, Zeuzem S, Pawlotsky JM.
    J Hepatol; 2012 Sep; 56 Suppl 1():S88-100. PubMed ID: 22300469
    [Abstract] [Full Text] [Related]

  • 10. Understanding the molecular targets for new therapeutical agents in hepatitis c infection.
    Vagu C, Sultana C, Ruţă S.
    Roum Arch Microbiol Immunol; 2013 Sep; 72(1):5-24. PubMed ID: 23947011
    [Abstract] [Full Text] [Related]

  • 11. New antiviral therapies in the management of HCV infection.
    Farnik H, Zeuzem S.
    Antivir Ther; 2012 Sep; 17(5):771-83. PubMed ID: 22626842
    [Abstract] [Full Text] [Related]

  • 12. New developments in HCV therapy.
    Kronenberger B, Zeuzem S.
    J Viral Hepat; 2012 Jan; 19 Suppl 1():48-51. PubMed ID: 22233414
    [Abstract] [Full Text] [Related]

  • 13. Antiviral activity of the new DAAs for the treatment of hepatitis C virus infection: virology and resistance.
    Chevaliez S.
    Clin Res Hepatol Gastroenterol; 2011 Dec; 35 Suppl 2():S46-51. PubMed ID: 22248694
    [Abstract] [Full Text] [Related]

  • 14. New HCV therapies on the horizon.
    Vermehren J, Sarrazin C.
    Clin Microbiol Infect; 2011 Feb; 17(2):122-34. PubMed ID: 21087349
    [Abstract] [Full Text] [Related]

  • 15. Telaprevir: a new hope in the treatment of chronic hepatitis C?
    Fowell AJ, Nash KL.
    Adv Ther; 2010 Aug; 27(8):512-22. PubMed ID: 20652658
    [Abstract] [Full Text] [Related]

  • 16. Different viral kinetics between hepatitis C virus genotype 1 and 2 as on-treatment predictors of response to a 24-week course of high-dose interferon-alpha plus ribavirin combination therapy.
    Yu ML, Chuang WL, Dai CY, Lee LP, Hsieh MY, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Tsai SL, Kuo HT.
    Transl Res; 2006 Sep; 148(3):120-7. PubMed ID: 16938649
    [Abstract] [Full Text] [Related]

  • 17. Boceprevir: an oral protease inhibitor for the treatment of chronic HCV infection.
    Trembling PM, Tanwar S, Dusheiko GM.
    Expert Rev Anti Infect Ther; 2012 Mar; 10(3):269-79. PubMed ID: 22397560
    [Abstract] [Full Text] [Related]

  • 18. Future hepatitis C virus treatment: interferon-sparing combinations.
    Gane E.
    Liver Int; 2011 Jan; 31 Suppl 1():62-7. PubMed ID: 21205140
    [Abstract] [Full Text] [Related]

  • 19. Serine protease inhibitors as anti-hepatitis C virus agents.
    Reiser M, Timm J.
    Expert Rev Anti Infect Ther; 2009 Jun; 7(5):537-47. PubMed ID: 19485794
    [Abstract] [Full Text] [Related]

  • 20. Treatment of chronic hepatitis C: current and future.
    Pawlotsky JM.
    Curr Top Microbiol Immunol; 2013 Jun; 369():321-42. PubMed ID: 23463207
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.